What they were paid
Amgen Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $140,000 | $219,773 | $0 | $20,123 | $379,896 |
| FY2024 | $140,000 | $219,906 | $0 | $147 | $360,053 |
| FY2023 | $130,000 | $209,791 | $0 | $20,129 | $359,920 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amgen Inc. DEF 14A filed April 7, 2026, accession 0001193125-26-145588, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Amgen pays directors a $140,000 cash retainer and $219,773 in RSUs.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the Amgen board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian J. Druker | Independent Director | $379,910 |
| Charles M. Holley Jr | Independent Director | $393,686 |
| Ellen J. Kullman | Independent Director | $400,168 |
| Greg C. Garland | Independent Director | $399,896 |
| Mary E. Klotman | Independent Director | $379,904 |
| Michael V. Drake | Independent Director | $367,484 |
| Robert A. Bradway | Chair of the Board | $0 |
| Robert A. Eckert | Lead Independent Director | $449,907 |
| S. Omar Ishrak | Independent Director | $380,481 |
| Tyler Jacks | Independent Director | $380,125 |
| Wanda M. Austin | Independent Director | $369,907 |
The full Amgen compensation record
free company briefThis page is one director within Amgen's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat